Pfizer-Wyeth deal talks heat up: sources
NEW YORK/PHILADELPHIA (Reuters) - Pfizer Inc, the world's largest drugmaker, is in talks to buy Wyeth, sources familiar with the situation said on Friday, and one source put the possible value of the deal at about $67 billion.<div class="feedflare">
<img src="http://feeds2.feedburner.com/~f/reuters/businessNews?d=41" border="0"></img> (http://feeds.reuters.com/~f/reuters/businessNews?a=jZZunGAH) <img src="http://feeds2.feedburner.com/~f/reuters/businessNews?i=AnEE5QgE" border="0"></img> (http://feeds.reuters.com/~f/reuters/businessNews?a=AnEE5QgE) <img src="http://feeds2.feedburner.com/~f/reuters/businessNews?i=EG8of43S" border="0"></img> (http://feeds.reuters.com/~f/reuters/businessNews?a=EG8of43S)
</div><img src="http://feeds2.feedburner.com/~r/reuters/businessNews/~4/GJBr2orf91c" height="1" width="1"/>
http://feeds.reuters.com/~r/reuters/businessNews/~3/GJBr2orf91c/idUSTRE50M1AQ20090124